$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RXO, Inc. (NYSE: RXO)
NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The...
Covered in this story
Analyst targets on Rxo Inc
- BMO Capital Markets: $28.6 → $30.3 by Oct 2027 · Market Perform via Investing.com
- JPMorgan: $28.6 → $30 by Oct 2027 · Neutral via Investing.com
- TD Cowen: $28.6 → $30.3 by Oct 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RXO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rxo Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.